Herbal Supplements, Prescription Drugs, Rx-to-OTC Products

Content

• Introduction
  • Objectives And Goals Of The Study
  • Contribution Of The Study And For Whom
  • Scope And Content
  • Methodology
  • Information Sources
  • Author's Credentials
  • Related BCC Work Credentials Including Work Done By Other Authors
• Executive Summary
  • Summary Table: Global Market Forecast For Herbal Supplements And Prescription Drugs To Treat Diseases Covered In This Report, Through 2011 ($ Millions)
  • Summary Figure: Global Market Forecast For Herbal Supplements And Prescription Drugs To Treat Diseases Covered In This Report, 2004-2011 ($ Millions)
• Overview
  • The Herbal Supplement, Prescription And Over-The-Counter Drug Markets
    • Definition Of An Herbal Supplement
  • U.S. Regulations Relating To Herbal Supplements
  • U.S. Issues First Herbal Supplement Standards
  • Nongovernment Oversight Of Herbal Product Quality
  • Overseas Regulations Relating To Herbal Supplements
  • Reimbursement For Herbal Products In The E.U.
    • The World Health Organization Releases Guidelines For Medicinal Herbs
  • Sources Of Raw Materials For Herbal Supplements
    • The Convention On International Trade In Endangered Species Of Wild Fauna And Flora
    • Terms Used To Describe The Sources Of Herbs Used In Supplements
  • Use Of Herbal Supplements Worldwide
    • Current Best-Selling Herbal Supplements And Indications For Herbal Supplements
  • Forecasting By Product
  • The Active Ingredients In And Indications For Popular Herbal Supplements
  • Adverse Herb-Drug Interactions
  • Leading Herbal Supplements Worldwide
    • Bilberry
    • Black Cohosh
    • Echinacea
    • Elderberry
    • Eleuthero
    • Evening Primrose
    • Garlic
    • Ginger
    • Ginkgo
    • Ginseng
    • Goldenseal
    • Grape Seed Extract
    • Green Tea
    • Horny Goat Weed
    • Kava Kava
    • Milk Thistle
    • Pygeum
    • St. John's Wort
    • Saw Palmetto
    • Soy
    • Valerian
    • Yohimbe
  • The Prescription Drug Industry
• Applications And Products
  • Herbal Supplement And Prescription Drug Markets To Treat Selected Diseases And Conditions
  • The Global Market For Herbal Supplements
    • The U.S. Market For Herbal Supplements
      • Top-Selling Herbal Supplements In The U.S.
  • Sales Of Herbal Supplements In The U.S. By Distribution Channel
  • Prescription Pharmaceutical Products
    • Best-Selling Drugs In 2005
  • Benign Prostatic Hyperplasia
    • Herbal Supplements For The Treatment Of Bph
    • The Market For Herbal Supplements To Treat Bph
    • Prescription Drugs To Treat Bph
      • Generic Proscar Introduced
      • The Market For Prescription Drugs To Treat Bph
    • Prescription Products In Development To Treat Bph
      • Bxl 628
      • Cetrorelix
      • Lonidamine
      • Qlt-0087
      • Silodosin
      • Tadalafil
  • Cognitive Disorders
    • Herbal Supplements To Treat Cognitive Disorders
    • The Market For Herbal Supplments To Treat Cognitive Disorders
    • Prescription Medications To Treat Cognitive Disorders
    • The Market For Prescription Medications To Treat Cognitive Disorders
    • Drugs In Development To Treat Cognitive Disorders
      • Namenda
      • Alzhemed
      • Flurizan
      • Namenda
      • Neramexane
  • Depression
    • History Of Antidepressant Medications
    • Herbal Supplements To Treat Depression
    • The Market For Herbal Supplements To Treat Depression
    • Prescription Drugs To Treat Depression
      • Cymbalta
      • Effexor/Effexor Xr
      • Lexapro
      • Remeron
      • Wellbutrin/Wellbutrin Sr/Wellbutrin Xl
      • Zoloft
      • Generic Versions Of Best-Selling Antidepressants
      • Revived Interest In Older Antidepressants
      • Antidepressants Recently Withdrawn From The Market
      • Fda Issues Warning On Use Of Antidepressants In Children And Adolescents, And Perhaps Adults
    • The Market For Prescription Drugs To Treat Depression
    • Prescription Products In Development To Treat Depression
      • Dvs-233 Sr
  • Erectile Dysfunction
    • Herbal Supplements To Treat Erectile Dysfunction
    • The Market For Herbal Supplements To Treat Erectile Dysfunction
    • Prescription Drugs To Treat Erectile Dysfunction
      • Marketed Products
      • Cialis
      • Levitra
      • Viagra
      • Zydena
    • The Market For Prescription Drugs To Treat Erectile Dysfunction
    • Drugs In Development To Treat Erectile Dysfuncion
      • Ta-1790
      • Uprima
      • Vasomax
  • Gastrointestinal Disorders
    • Dyspepsia
    • Heartburn/Gastroesophageal Reflux Disease
    • Nausea
    • The Market For Herbal Supplements To Treat Gastrointestinal Disorders
    • Pharmaceutical Products To Treat Gastrointestinal Disorders
      • Antinauseants
      • Locally Acting Antienauseants
      • Centrally Acting Antinauseants
      • Antidopaminergics
      • Anticholinergics
      • Miscellaneous Antinauseants
      • Market Size And Growth
      • H2 Inhibitors
      • The History Of H2 Inhibitors
      • Marketed Prescription Products
      • Market Size And Growth
      • Proton Pump Inhibitors
      • Aciphex/Pariet
      • Nexium
      • Prevacid/Takepron
      • Prilosec/Losec
      • Protonix/Pantozol/Protium
      • Zegerid
      • Generic Proton Pump Inhibitors
      • Comparison Of Proton Pump Inhibitors
      • Cost Of Proton Pump Inhibitors
      • The Market For Proton Pump Inhibitors
      • Loss Of Patent Protection By Leading Prescription Proton Pump Inhibitors
      • Prescription Gastrointestinal Products In Development
      • Prescription Versus Otc Proton Pump Inhibitors
      • Over-The-Counter Gastrointestinal Products
      • Antacids
      • Systemic Antacids
      • Sodium Bicarbonate
      • Nonsystemic Antacids
      • Calcium Carbonate
      • Aluminum Products
      • Magnesium Products
      • Combination Products
      • Market Size And Growth
      • Antinauseants
      • Market Size And Growth
      • H2 Inhibitors
      • Market Size And Growth
      • Proton Pump Inhibitors
      • Market Size And Growth
  • Hypercholesterolemia
    • Relationship Of Cholesterol To Cardiovascular Disease
    • Herbal Treatments For Hypercholesterolemia
      • Beta Sitosterol
    • The Market For Herbal Treatments For Hypercholesterolemia
    • Prescription Drugs For The Treatment Of Hypercholesterolemia
      • Bile Acid-Binding Resins
      • Hydroxymethylglutaryl-Coa Reductase Inhibitors
      • Marketed Statin Drugs
      • Fibric Acids
      • Nicotinic Acid And Derivatives
      • Probucol
      • Leading Products
      • Combination Products
      • Statin Drugs Show Promise In Treating Prostate Cancer
      • The Entry Of Generic Versions Of Blockbuster Cholesterol Drugs
      • The Medicare (Part D) Drug Benefit And Statin Drugs
    • The Market For Prescription Drugs To Treat Hypercholesterolemia
    • Prescription Products In Development For The Treatment Of Hypercholesterolemia
      • Agi-1067
      • Ceti-1
      • Etc-588
      • Etc-642
      • Fm-Vp4
      • Ks 01-019
      • Lipitor/Torcetrapib
      • Mk-524b
      • The Otc Market For Statin Drugs
  • Hypertension
    • Herbal Supplements For The Treatment Of Hypertension
    • The Market For Herbal Supplements To Treat Hypertension
    • Prescription Drugs For The Treatment Of Hypertension
    • The Market For Prescription Drugs To Treat Hypertension
    • Prescription Products In Development For The Treatment Of Hypertension
      • Aliskiren
      • Clevelox
      • Imidapril
      • Pw2101
      • Tadalafil
  • Insomnia
    • Herbal Treatments For Insomnia
    • The Market For Herbal Supplements To Treat Insomnia
    • Prescription Drugs For The Treatment Of Insomnia
      • Ambien/ Ambien Cr/ Stilnox
      • Benzodiazepines
      • Imovane
      • Lunesta
      • Rozerem
      • Sonata
    • The Market For Prescription Drugs To Treat Insomnia
    • Prescription Products In Development To Treat Insomnia
      • Ambien Odt
      • Apd125
      • Eplivanaserin Sr
      • Gaboxadol
      • Indiplon
      • Posidorm
    • Over-The-Counter Treatments For Insomnia
  • Menopause
    • Herbal Treatments For Menopausal Symptoms
    • The Market For Herbal Supplements To Treat Menopausal Symptoms
    • Prescription Drugs For The Treatment Of Menopausal Symptoms
    • The Market For Prescription Drugs To Treat Menopausal Symptoms
    • Prescription Drugs In Development For The Treatment Of Menopausal Symptoms
      • Menopause Formula 101
• Industry
  • Leading Players In The Nutritional Supplements Market
  • The Introduction Of The Medicare Drug Benefit Plan And What It Means For Drug Sales.
  • Generic Drugs
    • Therapeutic Equivalence
    • State Positive Formularies
    • Blockbuster Agents Experiencing Generic Challenge In The Prescription Pharmaceutical Market
    • Brand-Name Companies Enter Arrangements With Generics Firms To Not Introduce Generic Versions Of Best-Selling Drugs
    • The Introduction Of Authorized Generics
    • Fda Backlog In Reviewing Generic Drug Applications Slows The Entry Of Generic Drugs
    • The Rise And Fall In Generic Drug Prices
    • Growth In Sales Of Generic Drugs
    • The Tricky Generic Drug Business
    • Strategies Employed By Generics Drug Companies
      • First On The Market
      • Full Anda Pipelines
      • Specialization And Niche Marketing
      • Successful Patent Challenges
      • Exclusive Providers
      • Exclusive Supplier Arrangements
      • Breadth Of Product Line
      • Value-Added Products
      • Proprietary Products
      • Supergenerics
      • Generic Biologicals
      • Mergers
      • Cost-Effective Production
      • Cooperation With Branded Product Manufacturers
    • Novartis Takes The Lead Among Generic Manufacturers
  • The Fda Issues New Guidelines For Direct-To-Consumer Advertising
• Company Profiles
  • Herbal Supplement Companies
    • Gnc Corporation
      • Business Overview
      • Financial Information
      • Products
      • Company Strategy
    • Herbalife Ltd.
      • Business Overview
      • Financial Information
      • Products
      • Corporate Strategy
    • Natrol Inc.
      • Business Overview
      • Financial Information
      • Products
      • Corporate Strategy
    • Natural Alternatives International
      • Business Overview
      • Financial Information
      • Products
      • Corporate Strategy
    • Nature's Sunshine Products
      • Business Overview
      • Products
    • Nbty, Inc.
      • Business Overview
      • Financial Information
      • Products
      • Corporate Strategy
    • Nutraceuticals International
      • Business Overview
      • Financial Information
      • Products
      • Corporation Strategy
  • Pharmaceutical Companies
    • Abbott Laboratories
      • Business Overview
      • Financial Information
      • Products
      • Corporate Strategy
    • Atherogenics, Inc.
      • Business Overview
      • Financial Information
      • Products
      • Corporate Strategy
    • Biovail, Inc.
      • Business Overview
      • Financial Information
      • Products
      • Corporate Strategy
    • Forest Laboratories
      • Business Overview
      • Financial Information
      • Products
      • Corporate Strategy
    • Glaxosmithkline Plc
      • Business Overview
      • Financial Information
      • Products
    • Icos Corporation
      • Business Overview
      • Financial Information
      • Products
      • Corporate Strategy
    • Pfizer Corporation
      • Business Overview
      • Financial Information
      • Products
      • Corporate Strategy
    • Santarus, Inc.
      • Business Overview
      • Products
      • Corporate Strategy
    • Sepracor Inc.
      • Business Overview
      • Products
      • Corporate Strategy
• List Of Figures
  • Summary Table: Global Market Forecast For Herbal Supplements And Prescription Drugs To Treat Diseases Covered In This Report, Through 2011 ($ Millions)
  • Table 1 Active Ingredients And Indications For Selected Popular Herbal Supplements
  • Table 2 Concentrated Sources Of Gla
  • Table 3 Average Price Per Dry Pound Of Ginseng, Based On The Source Of The Root ($/Lb.)
  • Table 4 Global Market Forecast For Herbal Supplements For Diseases, Through 2011 ($ Millions)
  • Table 5 Global Market Forecast For Prescription Drug Categories For Diseases, Through 2011 ($ Millions)
  • Table 6 U.S. Market Forecast For Prescription Drug Categories For Diseases, Through 2011 ($ Millions)
  • Table 7 Global Market Forecast For Herbal Supplements By Region, Through 2011 ($ Millions)
  • Table 8 Estimated Global Market For Top 20 Herbal Treatments, Through 2011 ($ Millions)
  • Table 9 The Top-Selling Herbal Supplements In The U.S. Market In 2002 Through Food, Drug And Mass Market Channels* ($ Millions)
  • Table 10 U.S. Market Forecast For Top 20 Herbal Treatments, Through 2011 ($ Millions)
  • Table 11 Percentage Of The U.S. Herbal Supplements Market Held By Multiple-Herb Formulas, 2003-2005 (%)
  • Table 12 U.S. Market Forecast For Sales Of Herbal Treatments, By Distribution Channel, Through 2011 ($ Millions)
  • Table 13 The Top-Selling Herbal Supplements Sold Through Food, Drug And Mass Market Channels* In The U.S, 2004 And 2005 ($ Millions)
  • Table 14 Global Market Forecast For Herbal Supplements To Treat Benign Prostatic Hyperplasia, By Herb, Through 2011 ($ Millions)
  • Table 15 Global Market Forecast For Prescription Products To Treat Benign Prostatic Hyperplasia, Through 2011 ($ Millions)
  • Table 16 Estimated U.S. Market For Prescription Products To Treat Benign Prostatic Hyperplasia, Through 2011 ($ Millions)
  • Table 17 Selected Drugs In Phase Ii Or Later Development For The Treatment Of Bph
  • Table 18 Global Market Forecast For Herbal Products To Treat Cognitive Disorders, By Herb, Through 2011 ($ Millions)
  • Table 19 Global Market Forecast For Prescription Products To Treat Cognitive Disorders, By Product, Through 2011 ($ Millions)
  • Table 20 Estimated U.S. Market For Prescription Products To Treat Cognitive Disorders, Through 2011 ($ Millions)
  • Table 21 Selected Drugs In Phase Ii Or Later Development For The Treatment Of Cognitive Disorders
  • Table 22 Estimated Global Market For Herbal Products To Treat Depression, By Herb, Through 2011 ($ Millions)
  • Table 23 Estimated Global Market For Prescription Products To Treat Depression, By Product, Through 2011 ($ Millions)
  • Table 24 Estimated Market For Prescription Products To Treat Depression, By Geographic Market, 2005 ($ Millions)
  • Table 25 Selected Drugs In Phase Ii Or Later Development For The Treatment Of Depression
  • Table 26 Estimated Global Market For Herbal Products To Treat Erectile Dysfunction, By Herb, Through 2011 ($ Millions)
  • Table 27 Global Market Forecast For Erectile Dysfunction Drugs, By Product, Through 2011 ($ Millions)
  • Table 28 U.S. Market Forecast For Erectile Dysfunction Drugs, By Product, Through 2011 ($ Millions)
  • Table 29 Selected Drugs In Phase Ii Or Later Development For The Treatment Of Erectile Dysfunction
  • Table 30 Estimated Global Market For Herbal Products To Treat Gastrointestinal Disorders, By Herb, Through 2011 ($ Millions)
  • Table 31 Marketed Antinauseant Products
  • Table 32 Estimated Global Market For Prescription Antinauseants, Through 2011 ($ Millions)
  • Table 33 Estimated U.S. Market For Prescription Antinauseants, Through 2011 ($ Millions)
  • Table 34 Marketed H2 Inhibitors
  • Table 35 Global Market Forecast For Prescription H2 Inhibitors, Through 2011 ($ Millions)
  • Table 36 U.S. Market Forecast For Prescription H2 Inhibitors, Through 2011 ($ Millions)
  • Table 37 Branded Prescription Proton Pump Inhibitors And Suppliers
  • Table 38 Global Market Forecast For Prescription, Branded Proton Pump Inhibitors By Product, Through 2011 ($ Millions)
  • Table 39 U.S. Market Forecast For Prescription, Branded Proton Pump Inhibitors, By Product, Through 2011 ($ Millions)
  • Table 40 Patent Expiration For Selected Prescription Gastrointestinal Drugs, 2005-2013
  • Table 41 Selected Gastrointestinal Disorder Treatments In Phase Ii Or Later Development
  • Table 42 Marketed Otc Antacid Products
  • Table 43 U.S. Market Forecast For Otc Antacids, Through 2011 ($ Millions)
  • Table 44 Marketed Otc Antinauseants
  • Table 45 U.S. Market Forecast For Otc Antinauseants, Through 2011 ($ Millions)
  • Table 46 Marketed Otc H2 Inhibitors
  • Table 47 Estimated U.S. Market For Otc H2 Inhibitors, Through 2011 ($ Millions)
  • Table 48 Marketed Otc Proton Pump Inhibitors
  • Table 49 U.S. Market Forecast For Otc Proton Pump Inhibitors, Through 2011 ($ Millions)
  • Table 50 Global Market Forecast For Herbal Products To Treat Hypercholesterolemia, By Herb, Through 2011 ($ Millions)
  • Table 51 Classes Of Lipid-Lowering Drugs
  • Table 52 Lipid-Lowering Drugs Used In The Treatment Of Hypercholesterolemia In Coronary Artery Disease
  • Table 53 Statin Drugs Available Globally And Their Generic Availability In The U.S.
  • Table 54 Estimated Global Market For Prescription Products To Treat Hypercholesterolemia, By Product, Through 2011 ($ Millions)
  • Table 55 Estimated U.S. Market For Prescription Products To Treat Hypercholesterolemia, Through 2011 ($ Millions)
  • Table 56 Selected Drugs In Phase Ii Or Later Development For The Treatment Of Hypercholesterolemia And Related Conditions
  • Table 57 Estimated Global Market For Herbal Products To Treat Hypertension, By Herb, Through 2011 ($ Millions)
  • Table 58 Estimated Global Market For Prescription Products To Treat Hypertension, By Product, Through 2011 ($ Millions)
  • Table 59 U.S. Market Forecast For Prescription Products To Treat Hypertension, Through 2011 ($ Millions)
  • Table 60 Selected Drugs In Phase Ii Or Later Development For The Treatment Of Hypertension
  • Table 61 Frequency Of Insomnia Symptoms In The U.S. Adult Population (%)
  • Table 62 Estimated Global Market For Herbal Products To Treat Insomnia, By Herb, Through 2011 ($ Millions)
  • Table 63 Estimated Global Market For Prescription Products To Treat Insomnia, By Product, Through 2011 ($ Millions)
  • Table 64 Estimated U.S. Market For Prescription Products To Treat Insomnia, Through 2011 ($ Millions)
  • Table 65 Selected Drugs In Phase Ii Or Later Development For The Treatment Of Insomnia
  • Table 66 Estimated U.S. Market For Otc Products To Treat Insomnia, Through 2011 ($ Millions)
  • Table 67 Global Market Forecast For Herbal Products To Treat Menopausal Symptoms, By Herb, Through 2011 ($ Millions)
  • Table 68 Global Market Forecast For Prescription Products To Treat Menopausal Symptoms By Product, Through 2011 ($ Millions)
  • Table 69 Estimated U.S. Market For Prescription Products To Treat Menopausal Symptoms, Through 2011 ($ Millions)
  • Table 70 Selected Drugs In Phase Ii Or Later Development For The Treatment Of Menopausal Symptoms
  • Table 71 Leading Marketers Of Nutritional Supplements
  • Table 72 Market Shares Of Leading Marketers Of Nutritional Supplements In The U.S., March 2006 (%)
  • Table 73 Fda Orange Book Therapeutic Equivalence Rating Codes
• List Of Figures
  • Summary Figure: Global Market Forecast For Herbal Supplements And Prescription Drugs To Treat Diseases Covered In This Report, 2004-2011 ($ Millions)
  • Figure 1 Global Market Forecast For Prescription Drug Categories For Diseases, 2004-2011 ($ Millions)
  • Figure 2 U.S. Market Forecast For Prescription Drug Categories For Diseases, 2004-2011 ($ Millions)
  • Figure 3 Global Market Forecast For Herbal Supplements By Region, 2004-2011 ($ Millions)
  • Figure 4 Market Share Of Prescription Products To Treat Benign Prostatic Hyperplasia, 2005 (%)
  • Figure 5 Estimated Market For Prescription Products To Treat Depression, By Geographic Market, 2005 ($ Millions)
  • Figure 6 Global Market Forecast For Prescription H2 Inhibitors, 2004-2011 ($ Millions)
  • Figure 7 U.S. Market Forecast For Prescription H2 Inhibitors, 2004-2011 ($ Millions)